Parkinson's Disease Trial, Not Yet Recruiting NCT05545826 Sponsor: Stanford University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT05545826
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older
  • People who have been diagnosed with idiopathic Parkinson's disease at Hoehn and Yahr stage I (an early stage of Parkinson's disease — confirm with trial site if unsure which stage applies)
  • People who are fluent in English
  • People who have appropriate social support available, if needed during a period when Parkinson's medication is not active
  • People who are comfortable using technology, including a computer, email, the internet, and video calls for training and check-ins
  • People who are comfortable temporarily stopping their Parkinson's-related medication during in-person study visits
  • People who currently live in the United States

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have significant neurological or psychiatric conditions, including an acute confused state, active psychosis, or suicidal thoughts or tendencies
  • People who are currently misusing drugs or alcohol
  • People who are currently taking part in another clinical trial involving a drug, device, or biological treatment, or who have done so within the past 30 days (any exceptions would need to be approved by the trial's Principal Investigators)
  • People who are pregnant, breastfeeding, or planning to become pregnant
  • People who have physical limitations unrelated to Parkinson's disease that could affect movement-based assessments
  • People who have previously had a craniotomy (a surgical procedure to open the skull)
  • People who have previously had brain surgery
  • People who are unable to communicate effectively with the study team due to severe speech difficulties
  • People who experience excessive drooling
  • People whose hairstyle would prevent an EEG cap (a device placed on the head to measure brain activity) from being fitted properly
  • People who have abnormal sensation in their fingertips
  • People who have nasal (nose) problems unrelated to loss of smell

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 650-474-9547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
20 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov